
JHTV
@jhtechventures
JHTV brings the benefits of discovery to the world. Contact us! #Entrepreneurship #Innovation #StartUps
RTs & links are not endorsements or warranties.
ID: 89570058
http://ventures.jhu.edu 12-11-2009 23:28:16
7,7K Tweet
3,3K Takipçi
1,1K Takip Edilen

New for JHU researchers: "Intro to Intellectual Property" — a free, self-paced course from JHTV + the Johns Hopkins University Provost’s Office via LAD Academy! Designed for faculty, open to all with JHED, learn IP basics + research commercialization Enroll today! buff.ly/kbtzCqe



Got an innovation but not sure how to pitch it? Join us Aug 7 (12–1 PM) at JHTV for Pitching 101 with Kirsten Leute of Osage Univ. Partners. Learn how to approach investors, build a pitch deck & deliver with impact. Lunch provided! Register today: buff.ly/VXGg5mQ




What does it take to turn AI breakthroughs into FDA-approved health tech? At Johns Hopkins University, Sha Zhan is guiding startups from lab to market with real-world impact. From surgical robotics to diagnostic AI, her work is shaping the future of healthcare. buff.ly/3uISVwS


The Pava Marie LaPere Center for Entrepreneurship is leveling up! With new hires like Jake Drier & Deja Robinson, Johns Hopkins University is boosting support for student innovation. Their deep expertise in healthcare, data & regulation is a game-changer for startups navigating complex markets. buff.ly/UkwfYDy



Johns Hopkins startup Pearl Diagnostics just got FDA approval for its MycoMEIA™ Aspergillus Assay for Urine, a non-invasive test for Invasive Aspergillosis, a serious lung infection in immunocompromised people. Learn more: buff.ly/d7RyWgS


Diagnosing traumatic brain injuries is tough because symptoms are subtle or delayed. Hopkins Nursing Prof. Jessica Gill is using sweat to change that. Her lab is testing adhesive patches to detect brain injury biomarkers with the OLINK platform. Learn more: buff.ly/QoyXMUc




Researchers at Johns Hopkins University have developed an AI-driven framework to predict and overcome drug resistance in cancer cells. JHTV has filed patent protection for this game-changing technology in precision oncology. Learn more: buff.ly/8Hk93pL


In the latest episode of ScholarShare hosted by the National Academy of Inventors, hear how Christy Wyskiel turned 30+ years of entrepreneurial experience into a powerhouse of innovation at Johns Hopkins University. Tune in: youtu.be/d7G6fvEqeRA


Introducing the inaugural cohort of the GEM Fellowship at Johns Hopkins University. This 2-year program turns cutting-edge research into biotech innovation. Fellows receive: - Full funding - Commercialization training - Mentorship Learn more: buff.ly/KP5ZXsB





The FDA granted Breakthrough Device status to Quest Diagnostics’ Haystack MRD test. A blood-based tool developed by @HaystackOnco, a Johns Hopkins University company, detects minimal residual disease in stage 2 colorectal cancer. Learn more: buff.ly/ay5XYu7
